This week, Mark and Margaret speak with Dr. Gerard Anderson, Director of the Center for Hospital Finance and Management at the Johns Hopkins University Bloomberg School of Public Health. Dr. Anderson shares his expertise on health care payment reform and living well with chronic disease.
This week, Mark and Margaret speak with Dr. BJ Fogg, Director of the Persuasive Technology Lab at Stanford University, and author of Persuasive Technology: Using Computers to Change What We Think and Do. Dr. Fogg discusses how computers can change and motivate people and the potential for mobile health technologies to greatly impact health outcomes.
This week, Mark and Margaret speak with futurist Dr. Clement Bezold, co-founder and Chairman of the Institute for Alternative Futures. Dr. Bezold outlines his report on the future of health care in America, based on long term analysis of the impact of technology, genomics and health care reform.
This week, Mark and Margaret speak with physician and Governor of Oregon, John Kitzhaber, who discusses the state’s recent two billion dollar federal grant to deploy a program to reduce Medicaid costs using patient centered homes, community health workers, telemedicine and electronic health records.
This week, Mark and Margaret speak with Carolyn Miles, President and CEO of Save the Children. Miles discusses the organization’s three year study on global child mortality, focusing on newborns, and the strategies being employed to reduce mortality rates. Miles also discusses technological innovations that are allowing Save the Children to serve over 80 million children living in more than 120 countries, including the US.
This week, Mark and Margaret speak with Dr. Otis Brawley, Chief Medical Officer and Executive Vice President of the American Cancer Society. Dr. Brawley speaks about his new book, “How We Do Harm: A Doctor Breaks Ranks and Talks About Being Sick in America”. Dr Brawley explores racial and ethnic disparities in cancer survival and looks at the costs incurred from overuse of certain cancer screenings that are not leading to better health outcomes.